Published in J Invest Dermatol on August 12, 2013
Complement System Part II: Role in Immunity. Front Immunol (2015) 1.31
Non-invasive prognostic protein biomarker signatures associated with colorectal cancer. EMBO Mol Med (2015) 0.91
Complement factor I promotes progression of cutaneous squamous cell carcinoma. J Invest Dermatol (2014) 0.82
EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. J Invest Dermatol (2015) 0.82
Complement system in dermatological diseases - fire under the skin. Front Med (Lausanne) (2015) 0.76
From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers. Dis Markers (2016) 0.76
Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1. Cancer Lett (2015) 0.75
The role of the complement system in cancer. J Clin Invest (2017) 0.75
In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue. Cancer Genomics Proteomics (2016) 0.75
Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma. Oncotarget (2017) 0.75
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
Inflammation and cancer. Nature (2002) 53.78
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol (2010) 8.55
Complement regulators and inhibitory proteins. Nat Rev Immunol (2009) 4.46
Non-melanoma skin cancer. Lancet (2010) 4.11
Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol (2008) 2.19
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest (2012) 2.01
Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J (2004) 1.79
c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res (1990) 1.59
Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci (2000) 1.50
FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function. Immunol Today (1999) 1.48
Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem (2000) 1.46
Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today (1999) 1.40
Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1. J Immunol (2000) 1.30
p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Oncogene (2007) 1.27
Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res (2010) 1.22
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res (2004) 1.19
The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity. Biochem J (1997) 1.17
The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res (2010) 1.14
Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth. J Immunol (2007) 1.11
Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. J Immunol (2009) 1.06
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells. Br J Cancer (2002) 1.05
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. Br J Dermatol (2010) 1.04
Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol (1993) 1.02
Complement factor H as a marker for detection of bladder cancer. Clin Chem (2005) 0.98
Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma. Am J Pathol (2011) 0.97
Expression and localization of proteins of the complement system in human skin. J Clin Invest (1992) 0.94
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol (2008) 0.93
The possible role of factor H in colon cancer resistance to complement attack. Int J Cancer (2008) 0.90
Expression of terminal complement components by human keratinocytes. Mol Immunol (2007) 0.85
Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells. PLoS One (2012) 0.82
Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-gamma. Mol Immunol (2005) 0.81
Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol (2014) 0.91
Complement factor I promotes progression of cutaneous squamous cell carcinoma. J Invest Dermatol (2014) 0.82
EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. J Invest Dermatol (2015) 0.82
Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity. J Invest Dermatol (2016) 0.78
Expression of claudin-11 by tumor cells in cutaneous squamous cell carcinoma is dependent on the activity of p38δ. Exp Dermatol (2016) 0.77
In vitro model of bone to facilitate measurement of adhesion forces and super-resolution imaging of osteoclasts. Sci Rep (2016) 0.76
Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma. Oncotarget (2017) 0.75
An approach to comprehensive genome and proteome expression analyses in Schwann cells and neurons during peripheral nerve myelin formation. J Neurochem (2016) 0.75
Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage. PLoS One (2017) 0.75
Intensity of (18)F-FDG PET Uptake in Culture-Negative and Culture-Positive Cases of Chronic Osteomyelitis. Contrast Media Mol Imaging (2017) 0.75
Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma. Am J Pathol (2017) 0.75